BioCardia (BCDA) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026)
Powered by 
Analysis
BioCardia (BCDA) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 2.25% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 7.34% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 18.35% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -12.33% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | -3.86% |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | -23.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.53% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -51.52% |
| Sep 30, 2025 | -72.34% |
| Jun 30, 2025 | -72.13% |
| Mar 31, 2025 | -78.67% |
| Dec 31, 2024 | -64.89% |
| Sep 30, 2024 | -58.77% |
| Jun 30, 2024 | -56.12% |
| Mar 31, 2024 | -52.53% |
| Dec 31, 2023 | -44.71% |
| Sep 30, 2023 | -39.68% |
| Jun 30, 2023 | -31.86% |
| Mar 31, 2023 | -18.97% |
| Dec 31, 2022 | -6.59% |
| Sep 30, 2022 | 8.00% |
| Jun 30, 2022 | 10.87% |
| Mar 31, 2022 | 18.90% |
| Dec 31, 2021 | 25.52% |
| Sep 30, 2021 | 8.70% |